← Back to headlines

Roche axes Carmot obesity asset, 3 cancer drugs in R&D clear-out

This story is reported by Fierce Biotech. Read what other outlets are saying below, then open the original report for full details.

Roche axes Carmot obesity asset, 3 cancer drugs in R&D clear-out · NabkaNews